Pharmaceutical Commerce

FTC–Express Scripts Settlement Targets PBM Rebates, Transparency, and Patient Drug Costs

1. FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients. United States Federal Trade Commission. February 4, 2026. Accessed February 5, 2026.
WFMJ

FTC settles with Express Scripts to lower insulin costs

WASHINGTON - Federal regulators announced a settlement Wednesday with Express Scripts to change how the company handles prescription drug pricing. The agreement aims to lower out-of-pocket costs for ...